Drug Therapy Committee


Theodore Stern, MD, Interin Chair
Dena Alioto, RPh
Kate Barba, RN
Kathryn Beauchamp, RN, MSN
Theodore Benzer, MD
Kathryn Brush, RN
Margaret Clapp, MS, RPh
John Clark, MD
Nicole Devita, RPh
Jessica Dudley, MD
Robert Hallisey, MS, RPh

David Hooper, MD
Michael Langan, MD

Donald Lloyd-Jones, MD
Benjamin Matthews, MD
Regina Melanson, PharmD, RPh
Kathleen McKibbin, MD
Carl Rosow, MD
Nina Tolkoff-Rubin, MD
Jerry Younger, MD

Editor
Barbara Irby, MS, RPh

Web Design
Ron Imperiali, RP
h

 

 

Drug Therapy Committee Highlights: October 2003

Volume XIII, Issue 11
November 2003

Much Ado about Nothing – Again!
The Atorvastatin-Clopidogrel Interaction

Robert K. Hallisey, MS, RPh, Clinical Pharmacy Specialist, MGH

Adverse Drug Reactions: “What’s Your Reaction?”
Cross Sensitivity Between Sulfonamides and Silver Sulfadiazine
Tanya John, PharmD, Senior Attending Pharmacist, MGH and Colleen Collins, RPh, Senior Attending Pharmacist, MGH

Volume XIII, Issue 10
October 2003



Answering the Herbal Quandary
Carla J. Bouwmeester, PharmD, Attending Pharmacist, MGH


Drug Therapy Committee Highlights: August 2003

Volume XIII, Issue 9
September 2003


 

New Pain Policy and Guidelines Approved
Thomas E. Quinn, MSN, RN, AOCN, Project Director, MGH Cares About Pain Relief


Volume XIII, Issue 8
August 2003


Drug Therapy Committee Highlights: June 2003

Volume XIII, Issue 7
July 2003



Serevent Update
Nicole G. DeVita, RPh, MHP
Director of Pharmacy and Clinical Program Development
Partners Community HealthCare Inc.

Dean Hess, PhD, RRT
Assistant Director, Respiratory Care Services, MGH

Drug Therapy Committee Highlights: May 2003

Volume XIII, Issue 6
June 2003


Recent Updates to the Mass Health Drug List: Antihypertensives and Antidepressants
Angela McQueen, PharmD PCHI Clinical Pharmacist

Drug Therapy Committee Highlights: April 2003


Volume XIII, Issue 5
May 2003


Lower the Risk: The Case for Low-Molecular-Weight Heparins
Anthony J. Fatalo, MS, RPh, Senior Attending Pharmacist

Drug Therapy Committee Highlights: March 2003

Volume XIII, Issue 4
April 2003


Conscientious Use of Rofecoxib (Vioxx) 50mg
Thomas H. Lee, MD, PCHI Chief Medical Officer
Tara Abrams, PharmD, PCHI Pharmacy Programs Team Leader

Drug Therapy Committee Highlights: February 2003

Volume XIII, Issue 3

March 2003


Drug Therapy Committee Highlights: January 2003

Volume XIII, Issue 2
February 2003


The MGH Medication Patient Care Assistance Program: Moving Indigent Care From the Red Into the Black
Sami Ahmed, PharmD Pharmacy Practice Resident

The Evidence Is In: Diuretics Should Be First Choice for Hypertension
Thomas H. Lee, MD Chief Medical Officer, Partners Community HealthCare, Inc.

Volume XIII, Issue 1
January 2003